Bicyclo-octatriene derivatives, pharmaceutical compositions containing them and processes and intermediates for their production
申请人:FISONS plc
公开号:EP0043194A2
公开(公告)日:1982-01-06
There are described compounds of formula I
in which one of A, B and D represents hydrogen and the other two independently represent -CH2OR or -OR,
R represents hydrogen or phenylalkyl, and
R2 and R3, which may be the same or different, each represent hydrogen, alkyl or unsubstituted or substituted phenylalkyl,
and the pharmaceutically acceptable salts thereof.
There are also described processes for producing the compounds by reduction or hydrolysis and pharmaceutical, e.g. cardiac, compositions containing them.
compound of formula II,
in which one of A1, B1 and D1 represents hydrogen and the other two independently represent -CHO, -CH2OR1 or -OR1,
R' represents a blocking group or a group R as defined above, and
0 represents -CH2NR2R3, -CN or -CONR2R3 where R2 and R3 are as defined above, provided that R1 does not represent hydrogen when Q represents -CH2NR2R3,
所述化合物为式 I
其中 A、B 和 D 中的一个代表氢,另外两个独立地代表-CH2OR 或-OR、
R 代表氢或苯基烷基,以及
R2和R3可以相同或不同,各自代表氢、烷基或未取代或取代的苯基烷基、
及其药学上可接受的盐类。
此外,还描述了通过还原或水解生产这些化合物的工艺,以及含有这些化合物的药物组合物,如心药组合物。
式 II 的化合物、
其中 A1、B1 和 D1 中的一个代表氢,另外两个独立地代表-CHO、-CH2OR1 或-OR1、
R' 代表封端基团或如上定义的基团 R,以及
0 代表-CH2NR2R3、-CN 或-CONR2R3,其中 R2 和 R3 如上文所定义,但当 Q 代表-CH2NR2R3 时,R1 不代表氢、